189 related articles for article (PubMed ID: 22362133)
21. Relaxant effect of a water soluble carbon monoxide-releasing molecule (CORM-3) on spontaneously hypertensive rat aortas.
Failli P; Vannacci A; Di Cesare Mannelli L; Motterlini R; Masini E
Cardiovasc Drugs Ther; 2012 Aug; 26(4):285-92. PubMed ID: 22766583
[TBL] [Abstract][Full Text] [Related]
22. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
[TBL] [Abstract][Full Text] [Related]
23. Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury.
Zimmermann A; Leffler CW; Tcheranova D; Fedinec AL; Parfenova H
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2501-7. PubMed ID: 17630349
[TBL] [Abstract][Full Text] [Related]
24. Carbon monoxide released by CORM-A1 prevents yeast cell death via autophagy stimulation.
Figueiredo-Pereira C; Menezes R; Ferreira S; Santos CN; Vieira HLA
FEMS Yeast Res; 2019 Aug; 19(5):. PubMed ID: 31344236
[TBL] [Abstract][Full Text] [Related]
25. Carbon monoxide-releasing molecule-A1 inhibits Th1/Th17 and stimulates Th2 differentiation in vitro.
Nikolic I; Vujicic M; Stojanovic I; Stosic-Grujicic S; Saksida T
Scand J Immunol; 2014 Aug; 80(2):95-100. PubMed ID: 24845722
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
27. Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats.
Fagone P; Mangano K; Mammana S; Cavalli E; Di Marco R; Barcellona ML; Salvatorelli L; Magro G; Nicoletti F
Clin Immunol; 2015 Apr; 157(2):198-204. PubMed ID: 25701800
[TBL] [Abstract][Full Text] [Related]
28. Carbon Monoxide Releasing Molecule-A1 (CORM-A1) Improves Neurogenesis: Increase of Neuronal Differentiation Yield by Preventing Cell Death.
Almeida AS; Soares NL; Vieira M; Gramsbergen JB; Vieira HL
PLoS One; 2016; 11(5):e0154781. PubMed ID: 27144388
[TBL] [Abstract][Full Text] [Related]
29. The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide.
Roger S; Badier-Commander C; Paysant J; Cordi A; Verbeuren TJ; Félétou M
Br J Pharmacol; 2010 Nov; 161(5):1044-58. PubMed ID: 20977455
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
31. Carbon monoxide and its donors - their implications for medicine.
Adach W; Olas B
Future Med Chem; 2019 Jan; 11(1):61-73. PubMed ID: 30526059
[TBL] [Abstract][Full Text] [Related]
32. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
33. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.
Bauer N; Yuan Z; Yang X; Wang B
Biochem Pharmacol; 2023 Aug; 214():115642. PubMed ID: 37321416
[TBL] [Abstract][Full Text] [Related]
34. A carbon monoxide-releasing molecule (CORM-3) attenuates lipopolysaccharide- and interferon-gamma-induced inflammation in microglia.
Bani-Hani MG; Greenstein D; Mann BE; Green CJ; Motterlini R
Pharmacol Rep; 2006; 58 Suppl():132-44. PubMed ID: 17332683
[TBL] [Abstract][Full Text] [Related]
35. Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels.
Althaus M; Fronius M; Buchäckert Y; Vadász I; Clauss WG; Seeger W; Motterlini R; Morty RE
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):639-50. PubMed ID: 19251942
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the effects of the lipid-soluble CORM-2 and the water-soluble CORM-3 and CORM-A1 on platelet adhesion: The role of arachidonic acid metabolism.
Adach W; Olas B
Thromb Res; 2020 Apr; 188():61-64. PubMed ID: 32070829
[No Abstract] [Full Text] [Related]
38. Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs).
Motterlini R; Sawle P; Hammad J; Mann BE; Johnson TR; Green CJ; Foresti R
Pharmacol Res; 2013 Feb; 68(1):108-17. PubMed ID: 23253427
[TBL] [Abstract][Full Text] [Related]
39. Heme is required for carbon monoxide activation of mitochondrial BK
Rotko D; Bednarczyk P; Koprowski P; Kunz WS; Szewczyk A; Kulawiak B
Eur J Pharmacol; 2020 Aug; 881():173191. PubMed ID: 32422186
[TBL] [Abstract][Full Text] [Related]
40. Modulation of cellular bioenergetics by CO-releasing molecules and NO-donors inhibits the interaction of cancer cells with human lung microvascular endothelial cells.
Stojak M; Kaczara P; Motterlini R; Chlopicki S
Pharmacol Res; 2018 Oct; 136():160-171. PubMed ID: 30196104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
